Cancer Research
Overview
Cancer is the leading cause of death worldwide, causing many patients to suffer from severe pain. We strive to overcome resistance against existing cancer therapeutics and achieve the ultimate goal of conquering cancer. Extending attempts are being made to enhance the anti-tumor efficacy and expand indications for therapeutics in various cancer therapies including targeted therapy, immunotherapy, antibody therapy, and combination therapy.
In addition, we are making efforts to build a pipeline through open innovation utilizing artificial intelligence in the face of the accelerating digital transformation.
In addition, we are making efforts to build a pipeline through open innovation utilizing artificial intelligence in the face of the accelerating digital transformation.
Zoom Images
Combination therapy
- Mutation Driven
RAF, MKI
Mutation-driven inhibits the oncogenic signaling, cell proliferaton and cells expressing the mutant proteins
- Chemotherapy
CTx
Chemotherapy inhibits DNA synthesis and cell proliferation
- Antibodies
mAb, BsAb
A bispecific antibody is designed to bind to two different epitopes, either on the same or on different targets (developed by Beijing Hanmi Reseach center)
- Epigenetics
EZH1/2
Epigenetics controls in gene expressions that do not result from alterations in the DNA sequenc
- Immuno Oncology
IL-2, CCR4
Immuno-oncology uses the body immune system to help fight cancer